The Filing Desk

Escalade

ESCA · Nasdaq · Consumer Discretionary · Financials, fiscal 2016 to 2025

ESCA · Last close · November 13, 2026
$21.03
Value Escalade yourself

Escalade's revenue fell 4.5% to $240 million in fiscal 2025. Its operating margin was 7.8%, down from 8.0% a year earlier. Free cash flow was $28 million, down 16.2%. It paid out $11 million in dividends and buybacks, 40% of free cash flow. The diluted share count fell 1.3%.

ESCALADE, INCORPORATED Latest fiscal year ended December 31, 2025 10-K filed February 27, 2026 · 0001437749-26-006094 Updated
Revenue
$240M
4.5%
Operating margin
7.8%
0.2 pts
Net income
$14M
5.5%
Free cash flow
$28M
16.2%
Return on capital
7.7%
0.5 pts
Market cap
$292M
Nov 13 close
P/E
12.0x
On $1.75 EPS, 4 qtrs

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

Charts show fiscal years, from the 10-K filings.

What Escalade does

Escalade, based in Evansville, Indiana, makes, imports and distributes sporting goods and recreation products. Its brands cover archery (Bear Archery), table tennis (STIGA), basketball goals (Goalrilla, Goalsetter), pickleball (Onix), play systems, fitness gear, game tables, billiards, darts and outdoor games. It reports one segment, Sporting Goods.

It sells through major sporting goods retailers, specialty dealers, online retailers, its own e-commerce sites, department stores and mass merchants. It makes some products in the United States and imports others from South America and Asia, using contract manufacturers. It had 444 employees at December 31, 2025.

Sales depend heavily on a few customers: one customer accounted for approximately 19% of its revenues in 2025 and 2024, and another for approximately 11% in 2025.

Its biggest risks, as it describes them

  • Highly competitive markets that could limit its growth and cut profits.
  • Misjudging consumer demand, which could lose customers and lower sales.
  • Excess inventory, which has hurt its results before.
  • Strategic deals that may not produce the results it expects.
  • Dependence on a few large customers, and on contract manufacturers in other countries.
From Escalade's annual report on Form 10-K, filed February 27, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

From fiscal 2016 to 2025, earnings per share grew 2.4% a year and net income 2.0% a year, as buybacks cut the share count by 3%.

Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments440412
Debt incl. finance leases5895512618
Net debt (negative means net cash)539151217
Net debt to EBITDA1.4x2.8x2.2x0.8x0.3x
Debt to equity0.4x0.6x0.3x0.1x0.1x
Interest coverage21.1x7.0x3.3x8.7x22.4x
Current ratio3.5x4.8x4.4x3.9x4.3x
Quick ratio1.6x1.7x1.6x1.7x2.0x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Projections

Project Escalade's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.

Insider trades

Over the 12 months between November 14, 2025 and November 13, 2026, no insider bought Escalade shares on the open market, and 4 insiders sold $2.1 million.

Buys and sells by month
US$ millions, open-market purchases (up) and sales (down) by officers, directors and 10% owners in each month.
BoughtSold
DateInsiderTradeSharesPriceValueFiling
Nov 9, 2026Richard Fenton Baalmann JRDirectorSold2,000$21.00$42,000Form 4
Aug 13, 2026Edward E WilliamsDirectorSold2,373$20.99$49,809Form 4
Aug 12, 2026Edward E WilliamsDirectorSold362$20.96$7,588Form 4
Aug 11, 2026Edward E WilliamsDirectorSold30,315$20.98$636,009Form 4
Aug 6, 2026Richard Fenton Baalmann JRDirectorSold5,000$22.27$111,350Form 4
Aug 4, 2026Walter P. Glazer Jr.DirectorSold16,374$21.08$345,164Form 4
Aug 4, 2026Stephen WawrinChief Financial OfficerSold3,177$21.40$67,988Form 4
May 8, 2026Walter P. Glazer Jr.DirectorSold1,048$19.80$20,750Form 4
May 7, 2026Walter P. Glazer Jr.DirectorSold32,578$19.83$646,022Form 4
Dec 11, 2025Richard Fenton Baalmann JRDirectorSold5,490$13.00$71,370Form 4
Dec 10, 2025Richard Fenton Baalmann JRDirectorSold4,224$13.00$54,912Form 4
Dec 1, 2025Richard Fenton Baalmann JRDirectorSold286$13.35$3,818Form 4
The latest 12 of 13 trades. Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score4 of 97 of 99 of 9
Rule of 401.6%8.9%7.3%
Altman Z''7.438.949.74
Accruals ratio−14.0%−9.6%−7.7%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positivePassPassPass
Cash from operations is positivePassPassPass
Return on assets roseFailPassPass
Cash from operations exceeds net incomePassPassPass
Debt fell relative to assetsPassPassPass
Current ratio roseFailFailPass
Share count didn't riseFailFailPass
Gross margin roseFailPassPass
Revenue rose relative to assetsFailPassPass
F-score4 of 97 of 99 of 9
Companies that report no gross profit are scored on the other eight.

Compare

Put Escalade side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
EscaladeFY25−4.5%7.8%11.9%7.7%0.3x9
MasterCraftFY2622.8%−0.3%6.4%−0.2%−3.5x4Compare
Smith & Wesson BrandsFY2610.4%5.6%17.3%———Compare
Latham GroupFY257.3%5.6%7.0%4.1%2.6x7Compare
Sturm Ruger & CoFY251.9%−2.2%7.0%———Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

10 years of figures

Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue172177176180274314314264252240
Revenue growth7.7%3.3%−0.9%2.7%51.6%14.6%0.1%−16.0%−4.6%−4.5%
Gross profit44454542757774626265
Research and development2222223333
Operating income1515149333226182019
Net income1214207262418101314
Diluted EPS (US$)0.800.981.410.501.821.761.310.710.930.99
Diluted shares (millions)14141414141414141414
Cash flow
Cash from operations1213616319483631
Capital expenditure33326102222
Free cash flow1011414−3−96463428
Dividends paid6777888688
Share buybacks00037100023
Acquisitions1017115036000
Stock-based compensation0010112222
Balance sheet at fiscal year end
Cash and short-term investments12364440412
Debt incl. finance leases272400305895512618
Total assets151156150149221252299253226222
Total liabilities4944212382105140885749
Shareholders' equity102112128126139147158165169173
Margins and ratios
Gross margin25.8%25.2%25.6%23.5%27.3%24.6%23.5%23.4%24.7%26.9%
Operating margin8.5%8.2%7.9%5.1%12.1%10.2%8.4%6.8%8.0%7.8%
Net margin6.7%7.9%11.6%4.0%9.5%7.8%5.7%3.7%5.2%5.7%
Free cash flow margin5.5%6.0%2.1%7.7%−1.0%−2.8%2.1%17.6%13.5%11.9%
Rule of 40 (growth + FCF margin)13.2%9.3%1.2%10.4%50.5%11.8%2.1%1.6%8.9%7.3%
Return on capital8.7%10.1%8.2%6.1%18.2%13.9%9.3%6.0%7.2%7.7%
Return on equity11.6%13.2%17.0%5.7%19.6%17.1%11.8%6.1%7.8%8.0%
Return on assets7.8%9.2%13.4%4.9%14.0%10.3%6.5%3.6%5.4%6.1%
Net debt to EBITDA1.3x1.2x−0.2x−0.4x0.7x1.4x2.8x2.2x0.8x0.3x
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: Escalade's Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Escalade.